OPKO Health, Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
OPKO Health, Inc. (OPK) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.03 per share for the 3-month period ending 2011-12-31, per its 10-K filed 2013-03-18.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2013-03-18
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2011-12-31 was $0.03.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2011-09-30 was -$0.01.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2011-06-30 was $0.00.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2011-03-31 was $0.00.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2011 was $0.02.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2010 was -$0.02.
- OPKO Health, Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2009 was -$0.03.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|
| 2011-12-31 | $0.03 10-K · filed 2013-03-18 | $0.02 10-K · filed 2012-03-15 |
| 2011-09-30 | -$0.01 10-K · filed 2013-03-18 | |
| 2011-06-30 | $0.00 10-K · filed 2013-03-18 | |
| 2011-03-31 | $0.00 10-K · filed 2013-03-18 | |
| 2010-12-31 | -$0.02 10-K · filed 2012-03-15 | |
| 2009-12-31 | -$0.03 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |